Durham, NC, United States of America

Celia C Labranche

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Duke University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Celia C Labranche. Retrieved from https://idiyas.com/inventor/celia-c-labranche-17jdc3pm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Celia C. Labranche: Innovator in HIV Research

Introduction

Celia C. Labranche is a notable inventor based in Durham, North Carolina, known for her significant contributions to the field of immunology. With a focus on HIV research, her work aims to develop innovative methods for inducing immune responses to combat the virus.

Latest Patents

Celia is credited with one patent entitled "Compositions comprising modified HIV envelopes." This invention is directed at creating immunogens and methods for stimulating and maturing germline B cells through the reverse engineering of HIV-1 envelopes. Her groundbreaking approach represents a leap forward in the quest for effective HIV treatments.

Career Highlights

Celia C. Labranche is affiliated with Duke University, a prestigious institution that supports her innovative research endeavors. Her work not only showcases her scientific acumen but also contributes to the broader fight against HIV/AIDS.

Collaborations

Throughout her career, Celia has collaborated with esteemed colleagues such as Barton F. Haynes and David C. Montefiori. These partnerships have played a crucial role in advancing her research and the development of new therapeutic strategies.

Conclusion

Celia C. Labranche stands out as a dedicated inventor whose work is making an impact in the field of HIV research. With her innovative approach and collaborative spirit, she is paving the way for new possibilities in immunogen development and potential breakthroughs in vaccine research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…